Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.405 AUD | +5.19% | +6.58% | -14.74% |
May. 07 | Argent BioPharma Reports CFO Appointment | MT |
May. 07 | Argent BioPharma shares begin trading on OTCQB Venture Market | AN |
Sales 2022 | 4.73M 3.12M | Sales 2023 | 3.39M 2.24M | Capitalization | 16.75M 11.06M |
---|---|---|---|---|---|
Net income 2022 | -20M -13.2M | Net income 2023 | -20M -13.2M | EV / Sales 2022 | 9.75 x |
Net Debt 2022 | 2.47M 1.63M | Net Debt 2023 | 9.51M 6.28M | EV / Sales 2023 | 7.75 x |
P/E ratio 2022 |
-2.02
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 9.44% |
1 week | +6.58% | ||
Current month | -1.22% | ||
1 month | -2.41% | ||
3 months | +1.25% | ||
6 months | -38.64% | ||
Current year | -14.74% |
Managers | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 05-10-20 |
Yifat Steuer
COO | Chief Operating Officer | 53 | 22-10-03 |
Nadya Lisovoder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 05-10-20 |
Director/Board Member | - | 23-05-31 | |
Daniel Robinson
BRD | Director/Board Member | - | Nov. 30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.405 | +5.19% | 2,089 |
24-05-09 | 0.385 | +1.32% | 529 |
24-05-08 | 0.38 | -3.80% | 5,582 |
24-05-07 | 0.395 | +3.95% | 967 |
24-05-06 | 0.38 | 0.00% | 2,801 |
Delayed Quote Australian S.E., May 10, 2024 at 02:10 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |
- Stock Market
- Equities
- RGT Stock
- MXC Stock